Weiss Multi-Strategy Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,176	Closed	-$1.66M	–	784
2023 Q2	$1.66M	Buy	+42,176	New	+$1.49M	0.03%	495
2016 Q4	–	Sell	-11,000	Closed	-$507K	–	537
2016 Q3	$507K	Buy	11,000 +65	+0.6%	+$3.67K	0.03%	344
2016 Q2	$558K	Buy	+10,935	New	+$543K	0.04%	314

Weiss Multi-Strategy Advisers's ISEE Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 42,176 shares — an estimated $1.66M sold.

Weiss Multi-Strategy Advisers first reported a position in ISEE in Q2 2016 and held it in 3 quarters. The position peaked at $1.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Weiss Multi-Strategy Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 42,176 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.66M.
Weiss Multi-Strategy Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
Weiss Multi-Strategy Advisers's IVERIC bio, Inc. Common Stock position peaked at $1.66M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.